Highly Efficient Surface Passivation with Cation-Exchanged Quasi-2D Perovskites for High-Sensitivity and Low-Dose
Zhiyuan Wang1,2, Liangrui Yu1, Xin He1,2
1Key Laboratory of Flexible Optoelectronic Materials and Technology, Ministry of Education, Jianghan University, Wuhan 430056, China.
ACS Applied Materials & Interfaces
|December 8, 2025
Summary
Researchers developed a new passivation method for perovskite X-ray detectors, significantly improving low-dose imaging performance. This advancement addresses defects in perovskite flat-panel detectors (FPDs) for clearer, high-resolution medical and industrial imaging.
Area of Science:
- Materials Science
- Medical Imaging Technology
- Solid-State Physics
Background:
- Perovskite-based X-ray flat-panel detectors (FPDs) offer potential for next-generation low-dose, high-resolution imaging.
- Polycrystalline thick films in FPDs suffer from interfacial defects, leading to nonradiative recombination, increased dark current, reduced sensitivity, and poor contrast-to-noise ratio (CNR).
Purpose of the Study:
- To develop a universal strategy for passivating interfacial defects in perovskite FPDs.
- To enhance the performance of perovskite FPDs for low-dose and high-resolution X-ray imaging applications.
Main Methods:
- A sequential thermal evaporation and liquid-phase reaction (STELR) method was employed to create a quasi-2D perovskite passivation layer on 3D perovskites.
- This cation-exchange strategy aims to reduce surface trap density and suppress noise in the detectors.
Main Results:
- The STELR passivation reduced surface trap density by nearly an order of magnitude.
- Noise current density was suppressed to 6 × 10-14A Hz-1/2.
- The passivated detector demonstrated high sensitivity (59,040 μC Gyair-1 cm-2), a low detection limit (18.6 nGyair s-1), and superior spatial resolution (0.71 lp/pixel).
Conclusions:
- The developed passivation strategy effectively mitigates interfacial defects in perovskite FPDs.
- The enhanced detectors maintain high-quality X-ray imaging (CNR = 2.09) even at ultralow doses (29.9 μGyair).
- This technology holds significant potential for advancing clinical and industrial low-dose imaging systems.


